Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Annunziato S, de Ruiter JR, Henneman L, Brambillasca CS, Lutz C, Vaillant F, Ferrante F, Drenth AP, van der Burg E, Siteur B, van Gerwen B, de Bruijn R, van Miltenburg MH, Huijbers IJ, van de Ven M, Visvader JE, Lindeman GJ, Wessels LFA, Jonkers J.
Annunziato S, et al. Among authors: vaillant f.
Nat Commun. 2019 Jan 23;10(1):397. doi: 10.1038/s41467-019-08301-2.
Nat Commun. 2019.
PMID: 30674894
Free PMC article.